Scot H Simpson

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. pmc Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, 3126 Dentistry Pharmacy Centre, University of Alberta, Edmonton, AB, Canada, T6G 2N8
    J Gen Intern Med 26:1336-44. 2011
  2. pmc Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta, Canada
    Diabetes Care 34:20-6. 2011
  3. pmc A meta-analysis of the association between adherence to drug therapy and mortality
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2N8
    BMJ 333:15. 2006
  4. doi request reprint Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial
    Fizza Gilani
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Ann Pharmacother 47:43-8. 2013
  5. ncbi request reprint The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines
    Diana Rucker
    University of Alberta, 2E3 07 Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112th St, Edmonton, Alberta, Canada
    Diabetes Care 29:2506-8. 2006
  6. doi request reprint Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs
    Dean T Eurich
    Department of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Am J Med 123:47-53. 2010
  7. ncbi request reprint Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 24:389-94. 2004
  8. pmc Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
    Scot H Simpson
    Institute of Health Economics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alta
    CMAJ 174:169-74. 2006
  9. pmc The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining?
    Dean T Eurich
    School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Diabetes Care 31:2136-42. 2008
  10. ncbi request reprint Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus
    Dean T Eurich
    Institute of Health Economics, Edmonton, Alberta, Canada
    Pharmacotherapy 25:810-6. 2005

Collaborators

Detail Information

Publications28

  1. pmc Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, 3126 Dentistry Pharmacy Centre, University of Alberta, Edmonton, AB, Canada, T6G 2N8
    J Gen Intern Med 26:1336-44. 2011
    ..This meta-analysis explored the relationship between aspirin dose and prevention of cardiovascular events...
  2. pmc Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta, Canada
    Diabetes Care 34:20-6. 2011
    ..To evaluate the effect of adding pharmacists to primary care teams on the management of hypertension and other cardiovascular risk factors in patients with type 2 diabetes...
  3. pmc A meta-analysis of the association between adherence to drug therapy and mortality
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2N8
    BMJ 333:15. 2006
    ..To evaluate the relation between adherence to drug therapy, including placebo, and mortality...
  4. doi request reprint Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial
    Fizza Gilani
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Ann Pharmacother 47:43-8. 2013
    ..Antiplatelet therapy is recommended as part of a strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. However, compliance with these guideline-recommended therapies appears to be less than ideal...
  5. ncbi request reprint The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines
    Diana Rucker
    University of Alberta, 2E3 07 Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112th St, Edmonton, Alberta, Canada
    Diabetes Care 29:2506-8. 2006
  6. doi request reprint Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs
    Dean T Eurich
    Department of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Am J Med 123:47-53. 2010
    ..To test this hypothesis, we examined a prospective population-based cohort predisposed to pneumonia: elderly patients (> or =65 years) who had survived hospitalization for pneumonia...
  7. ncbi request reprint Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 24:389-94. 2004
    ..To determine the effect of enhanced pharmacist care on cholesterol management in patients with and without diabetes mellitus...
  8. pmc Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
    Scot H Simpson
    Institute of Health Economics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alta
    CMAJ 174:169-74. 2006
    ..The purpose of this study was to determine if the risk of death changes with level of exposure to sulfonylurea drugs...
  9. pmc The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining?
    Dean T Eurich
    School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Diabetes Care 31:2136-42. 2008
    ..We aimed to evaluate the changes in cardiovascular-related health care utilization (drug therapies, hospitalizations) and mortality for the diabetic population during a 9-year period in Saskatchewan, Canada...
  10. ncbi request reprint Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus
    Dean T Eurich
    Institute of Health Economics, Edmonton, Alberta, Canada
    Pharmacotherapy 25:810-6. 2005
    ..To determine whether metformin therapy, compared with sulfonylurea therapy, is associated with a delayed onset of secondary failure in patients with type 2 diabetes mellitus...
  11. ncbi request reprint Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia
    Scot H Simpson
    Institute of Health Economics, 10405 Jasper Ave, Edmonton, Alberta T5J 3N4, Canada
    Respir Care Clin N Am 11:1-13. 2005
    ..Paper does not change practice, and the creation and mailing out of a practice guideline for the treatment of CAP is only the first necessary step in translating good evidence into everyday clinical practice...
  12. ncbi request reprint Development and validation of a survey to assess barriers to drug use in patients with chronic heart failure
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 22:1163-72. 2002
    ..Conclusion. The BMU survey demonstrated reasonable reliability and validity characteristics in this first clinical experience. Despite high adherence, patients still reported barriers that may hinder optimal drug use...
  13. doi request reprint Changes in Thiazolidinedione Use and Outcomes Following Removal of a Prior-authorization Policy: Controlled Time-Series Analysis
    John Michael Gamble
    School of Pharmacy, Memorial University of Newfoundland, St John s, Newfoundland and Labrador Alliance for Canadian Health Outcomes Research in Diabetes ACHORD School of Public Health Department of Medicine, Division of General Internal Medicine, University of Alberta Mazankowski Alberta Heart Institute Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
    Med Care 52:47-55. 2014
    ..The aim of this study was to assess the impact of removing prior-authorization restrictions on the use of thiazolidinediones (TZDs) and outcomes...
  14. pmc Hypertension treatment and control rates: chart review in an academic family medicine clinic
    Sara J Houlihan
    University of Alberta, Edmonton, AB T6G 2N8
    Can Fam Physician 55:735-41. 2009
    ..To characterize hypertension management in an academic family medicine clinic...
  15. pmc Evaluating the views of paramedics, cardiologists, emergency department physicians and nurses on advanced prehospital management of acute ST elevation myocardial infarction
    Naheed A Rajabali
    Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta T6G 2B7, Canada
    Can J Cardiol 25:e323-8. 2009
    ..Understanding perceived barriers to and facilitators of PHM implementation may support the expansion of programs, with associated patient benefit...
  16. doi request reprint Pharmacist care of patients with heart failure: a systematic review of randomized trials
    Sheri L Koshman
    Division of Cardiology, Faculty of Medicine and Dentistry, EPICORE Centre COMPRIS, University of Alberta, 220 College Plaza, 8215 112 St NW, Edmonton, Alberta, AB T6G 2C8 Canada
    Arch Intern Med 168:687-94. 2008
    ..To clarify the role of pharmacists in the care of patients with HF, we performed a systematic review evaluating the effect of pharmacist care on patient outcomes in HF...
  17. ncbi request reprint Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study
    Thomas Jeerakathil
    Division of Neurology, University of Alberta, Edmonton, Alberta, Canada, T6G 2B7
    Stroke 38:1739-43. 2007
    ..We determined the incidence of stroke in people newly treated for type 2 diabetes...
  18. pmc Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies
    Donna L McLean
    Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton
    Can J Cardiol 22:855-60. 2006
    ..Many patients with diabetes also have hypertension, greatly increasing their risk for cardiovascular disease. It has been suggested that hypertension is poorly treated in those with diabetes...
  19. ncbi request reprint Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
    Jeffrey A Johnson
    Department of Public Health Sciences, University of Alberta, Edmonton, Canada
    Diabetes Care 25:2244-8. 2002
    ..The aim of this study was to examine the relationship between use of metformin and sulfonylurea and mortality in new users of these agents...
  20. doi request reprint Use patterns of antidiabetic regimens by patients with type 2 diabetes
    Ahmed S Abdelmoneim
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Can J Diabetes 37:394-400. 2013
    ..To describe the use patterns of metformin-based antidiabetic regimens in patients with type 2 diabetes and to identify predictors of initiating metformin monotherapy...
  21. doi request reprint A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model
    Suliman A Alghurair
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
    J Clin Hypertens (Greenwich) 14:877-86. 2012
    ..The complexity of adherence behavior requires robust self-report measurements and the inclusion of barriers relevant to each unique patient population and intervention...
  22. pmc Angiotensin receptor blockers and risk of myocardial infarction: systematic review
    Michael A McDonald
    Division of Cardiology, University of Alberta, 2C2 WMC, University of Alberta Hospital, 8440 112 Street, Edmonton, AB, Canada T6G 2B7
    BMJ 331:873. 2005
    ..To evaluate the effect of angiotensin receptor blockers on the risk of myocardial infarction in patients at risk for cardiovascular events...
  23. ncbi request reprint Physician-perceived barriers to adopting a critical pathway for unity-acquired pneumonia
    Sumit R Majumdar
    Department of Medicine, University of Alberta, Edmonton
    Jt Comm J Qual Saf 30:387-95. 2004
    ..After one year (November 2000-November 2001), the pathway had reduced average length of stay by 1 day (from 10.8 to 9.8 days, p < .001). However, great variation was observed in physician adherence to the pathway...
  24. ncbi request reprint Development of educational materials for congestive-heart-failure patients
    Miriam Fradette
    Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    Am J Health Syst Pharm 61:386-9. 2004
  25. doi request reprint Prevalence of High On-treatment Platelet Reactivity in Diabetic Patients Treated with Aspirin
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada Electronic address
    Am J Med 127:95.e1-9. 2014
    ..This systematic review examined the relationship between daily aspirin dose and prevalence of HTPR in patients with diabetes...
  26. ncbi request reprint A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    Ross T Tsuyuki
    Epidemiology Coordinating and Research EPICORE Centre, Division of Cardiology, University of Alberta, 213 Heritage Medical Research Centre, Edmonton, Alberta, Canada T6G 2S2
    Arch Intern Med 162:1149-55. 2002
    ..This study aimed to determine the effect of a program of community pharmacist intervention on the process of cholesterol risk management in patients at high risk for cardiovascular events...
  27. pmc Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP)
    Charlotte Jones
    University of Calgary, Calgary, Canada
    Can J Cardiol 24:561-7. 2008
    ..High blood pressure (BP) is an established and modifiable cardiovascular risk factor; however, awareness and management of this primarily asymptomatic disease remains suboptimal...
  28. pmc The cost of major comorbidity in people with diabetes mellitus
    Scot H Simpson
    Institute of Health Economics, Edmonton, Alta
    CMAJ 168:1661-7. 2003
    ..Information on the economic impact of diabetes and its complications on the Canadian health care system is limited...